Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics. Nogrady B. BMJ 2023;382:p1599.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nogrady B. Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics. BMJ 2023;382:p1599.
PMID: 37433614